Art

J-GLOBAL ID：201802271849934254   Reference number：18A1058929

Prediction of response to cancer chemotherapy using immunohistochemical staining

免疫組織化学染色によるがん化学療法の感受性予測

Author (1)： KAMOSHIDA SHINGO (神戸大学大学院保健学研究科病態解析学領域)
Material： 電気泳動(Web)  (Electrophoresis Letters (Web))
Volume： 61  Issue： 2  Page： 124-127(J-STAGE)  Publication year： 2017 
JST Material Number： U0147A  ISSN： 2189-2636  Document type： Article
Article type： 解説  Country of issue： Japan (JPN)  Language： JAPANESE (JA)

Thesaurus term： *drug therapy ,...
Semi thesaurus term： genetic variation ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A1058929&from=J-GLOBAL&jstjournalNo=U0147A") }}

Author keywords (10)： immunohistochemical staining ,  cancer chemotherapy ,  companion diagnostics assay ,  companion biomarker ,  solute carrier transporter ,  immunohistochemical staining ,  cancer chemotherapy ,  companion diagnostics assay ,  companion biomarker ,  solute carrier transporter

JST classification (4)： Drug therapy(=pharmacotherapy)for tumors  (GE03032C) ,  Pathological tests  (GC02040S) ,  Tumors(=neoplasms)of digestive system  (GH04000D) ,  Clinical application of antitumor(=antineoplastic)drugs  (GW16020L)

Substance index (1)： Imatinib

Reference (13)：

• 1) Yaziji H, Taylor CR, Goldstein NS, et al. Consensus recommendations on estrogen receptor testing in breast cancer by immunohistochemistry. Appl Immunohistochem Mol Morphol. 2008;16:513-520.
• 2) Medinger M, Drevs J. Receptor tyrosine kinases and anticancer therapy. Curr Pharm Des. 2005;11:1139-1149.
• 3) Ross JS. Update on HER2 testing for breast and upper gastrointestinal tract cancers. Biomark Med. 2011;5:307-318.
• 4) Lee JA, Bubendorf L, Stahel R, et al. Testing for anaplastic lymphoma kinase rearrangement to target crizotinib therapy: oncology, pathology and health economic perspectives. Expert Rev Anticancer Ther. 2013;13:625-636.
• 5) Croom KF, Perry CM. Imatinib mesylate: in the treatment of gastrointestinal stromal tumours. Drugs 2003;63:513-522.

Terms in the title (4)： 免疫組織化学染色 ,  がん化学療法 ,  感受性 ,  予測